These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Phosphodiesterase inhibitor for erectile dysfunction. No less effective in the diabetic patient]. MMW Fortschr Med; 2002 Jul; 144(29-30):56. PubMed ID: 12219619 [No Abstract] [Full Text] [Related]
3. [Perspective on the role of Rho-kinase inhibitor in the treatment of diabetic vascular complications]. Utsunomiya K Nihon Rinsho; 2010 Nov; 68 Suppl 9():190-4. PubMed ID: 21661156 [No Abstract] [Full Text] [Related]
4. Olprinone, a PDE3 inhibitor, modulates the inflammation associated with myocardial ischemia-reperfusion injury in rats. Di Paola R; Mazzon E; Paterniti I; Impellizzeri D; Bramanti P; Cuzzocrea S Eur J Pharmacol; 2011 Jan; 650(2-3):612-20. PubMed ID: 21035441 [TBL] [Abstract][Full Text] [Related]
5. [From the Cochrane Library: Phosphodiesterase inhibitors are effective in treating erectile dysfunction in diabetic men]. Hamerlynck JV; Middeldorp S; Hooft L Ned Tijdschr Geneeskd; 2007 Sep; 151(38):2101-4. PubMed ID: 17948826 [TBL] [Abstract][Full Text] [Related]
6. [After the HOPE Study. ACE inhibitor now for every diabetic patient?. Interview by Dr. Dirk Einecke]. Yusuf S MMW Fortschr Med; 2000 Nov; 142(44):10. PubMed ID: 11107797 [No Abstract] [Full Text] [Related]
9. [Antioxidants in the combined therapy of diabetic angiopathies]. Bobyreva LE Eksp Klin Farmakol; 1998; 61(1):74-80. PubMed ID: 9575419 [TBL] [Abstract][Full Text] [Related]
10. Specific aspects of erectile dysfunction in endocrinology. Miralles-García JM; García-Díez LC Int J Impot Res; 2004 Oct; 16 Suppl 2():S10-2. PubMed ID: 15496851 [TBL] [Abstract][Full Text] [Related]
11. [Progress on the drug therapy for diabetic microangiopathies: RA system inhibitor]. Higashiura K; Shimamoto K Nihon Rinsho; 2005 Jun; 63 Suppl 6():144-9. PubMed ID: 15999698 [No Abstract] [Full Text] [Related]
12. Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats. Inkster ME; Cotter MA; Cameron NE Eur J Pharmacol; 2007 Apr; 561(1-3):63-71. PubMed ID: 17291486 [TBL] [Abstract][Full Text] [Related]
13. [The effect of PKC inhibitor on diabetic vascular complications]. Koya D Nihon Rinsho; 2010 Nov; 68 Suppl 9():160-5. PubMed ID: 21661152 [No Abstract] [Full Text] [Related]
14. [Progress on the drug therapy for diabetic microangiopathies: PKCbeta inhibitor]. Koya D; Kashiwagi A Nihon Rinsho; 2005 Jun; 63 Suppl 6():139-43. PubMed ID: 15999697 [No Abstract] [Full Text] [Related]
16. [Progress on the drug therapy for diabetic microangiopathies: aldose reductase inhibitor]. Hotta N Nihon Rinsho; 2005 Jun; 63 Suppl 6():127-35. PubMed ID: 15999695 [No Abstract] [Full Text] [Related]
17. [Aminoguanidine]. Kawano M; Kawakami M Nihon Rinsho; 1997 Nov; 55 Suppl():221-4. PubMed ID: 9434471 [No Abstract] [Full Text] [Related]
18. The diabetic with renal impairment. Tallis GA; Phillips PJ; Popplewell PY Aust Fam Physician; 1997 Sep; 26(9):1091-2. PubMed ID: 9382724 [No Abstract] [Full Text] [Related]
19. [Arterial hypertension in the diabetic: support of most of its complications]. Eliahou HE; Hellberg B Journ Annu Diabetol Hotel Dieu; 1988; ():97-104. PubMed ID: 3050239 [No Abstract] [Full Text] [Related]
20. The pharmacology of S 1702, a new highly effective oral antidiabetic drug with unusual properties. 2. Protective activity of S 1702 on the microvascular system in normal and diabetic rats. Duhault J; Lebon F Arzneimittelforschung; 1972 Oct; 22(10):1686-90. PubMed ID: 4677057 [No Abstract] [Full Text] [Related] [Next] [New Search]